Related Experiment Videos

Closing in on the cause of SARS

The Lancet. Infectious Diseases

|May 3, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial.

The Lancet. Infectious diseases·2026

Evaluating the impact of antiviral post-exposure prophylaxis for health-care workers during orthoebolavirus outbreaks: a modelling study.

The Lancet. Infectious diseases·2026

Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study.

The Lancet. Infectious diseases·2026

Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial.

The Lancet. Infectious diseases·2026

Epidemiological impact of a dual-action insecticidal coating applied to Aedes aegypti breeding sites on dengue transmission in Colombia: a cluster-randomised trial.

The Lancet. Infectious diseases·2026

Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descending, dose-escalating, double-blind, randomised, placebo-controlled study.

The Lancet. Infectious diseases·2026

See all related articles